---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-035166"
form_type: "8-K"
ticker: "OGEN"
cik: "0001174940"
company_name: "ORAGENICS INC"
filed_at: "2024-09-05T23:59:59+00:00"
generated_at: "2026-05-31T06:11:40.543130+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Oragenics raises $4.45M in public offering; sold shares and pre-funded warrants at $0.55

## Summary
- Gross proceeds of ~$4.45M from offering of 3,078,378 shares and 5,028,206 pre-funded warrants.
- Net proceeds ~$3.79M after placement agent fees (7%) and estimated expenses.
- Proceeds to fund ONP-002 development for mild traumatic brain injury and general working capital.
- Post-offering shares outstanding: 8,659,071 common shares plus 5,028,206 pre-funded warrants.
- Placement agent Dawson James receives 7% cash fee and warrants for 5% of securities sold at 125% of offering price.

## SEC filing metadata
- accession: 0001493152-24-035166
- form_type: 8-K
- ticker: OGEN
- cik: 0001174940
- company_name: ORAGENICS INC
- filed_at: 2024-09-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1174940/000149315224035166/0001493152-24-035166-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1174940/000149315224035166/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-035166
- JSON: https://secwatch.observer/filing/0001493152-24-035166.json
- Plain text: https://secwatch.observer/filing/0001493152-24-035166.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.